1. Home
  2. SJ vs SCYX Comparison

SJ vs SCYX Comparison

Compare SJ & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scienjoy Holding Corporation

SJ

Scienjoy Holding Corporation

N/A

Current Price

$0.90

Market Cap

41.6M

Sector

Technology

ML Signal

N/A

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$4.37

Market Cap

44.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SJ
SCYX
Founded
2011
1999
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.6M
44.0M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
SJ
SCYX
Price
$0.90
$4.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
68.9K
94.2K
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.36
EPS
N/A
N/A
Revenue
N/A
$257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$608.78
P/E Ratio
$21.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.57
52 Week High
$1.63
$5.62

Technical Indicators

Market Signals
Indicator
SJ
SCYX
Relative Strength Index (RSI) 37.79 54.29
Support Level $0.77 $0.67
Resistance Level $0.84 $5.62
Average True Range (ATR) 0.12 0.37
MACD -0.00 -0.07
Stochastic Oscillator 5.80 37.01

Price Performance

Historical Comparison
SJ
SCYX

About SJ Scienjoy Holding Corporation

Scienjoy Holding Corp is a provider of mobile live streaming platforms in China and focuses on interactive show live streaming from broadcasters to users. It operates a mobile live streaming business by which it provides live streaming entertainment from professional broadcasters to end-users, allowing for the operation of live social video communities. Using its mobile applications, users can select broadcasters and enter real-time video rooms to interact with them. In addition to the real-time interaction, users can also view photos posted by broadcasters in their personal pages, leave comments, and engage in private chats with broadcasters when such broadcasters are not streaming. In addition, users can also play simple, fun games using virtual currencies within the video rooms.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: